Volume 27, Number 2—February 2021
Research
Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands
Liselotte van Asten
, Carel N. Harmsen, Lenny Stoeldraijer, Don Klinkenberg, Anne C. Teirlinck, Marit M.A. de Lange, Adam Meijer, Jan van de Kassteele, Arianne B. van Gageldonk-Lafeber, Susan van den Hof, and Wim van der Hoek
, Carel N. Harmsen, Lenny Stoeldraijer, Don Klinkenberg, Anne C. Teirlinck, Marit M.A. de Lange, Adam Meijer, Jan van de Kassteele, Arianne B. van Gageldonk-Lafeber, Susan van den Hof, and Wim van der Hoek
Table 1
Total, excess, and reported COVID-19 deaths during 25 weeks of the COVID-19 epidemic, the Netherlands*
| Week† | Week start (Thursday) | Week end (Wednesday) | No. observed all-cause deaths | No. expected all-cause deaths (baseline) | No. excess deaths | % Above expected | No. reported COVID-19 deaths | Ratio (excess vs. reported COVID-19 deaths) |
|---|---|---|---|---|---|---|---|---|
| 1 | 2019 Dec 26 | 2020 Jan 1 | 2,982 | 2,972 | 10 | 0 | NA | NA |
| 2 | 2020 Jan 2 | 2020 Jan 8 | 3,166 | 2,985 | 181 | 6 | NA | NA |
| 3 | 2020 Jan 9 | 2020 Jan 15 | 3,342 | 2,996 | 346 | 12 | NA | NA |
| 4 | 2020 Jan 16 | 2020 Jan 22 | 2,986 | 3,004 | −18 | −1 | NA | NA |
| 5 | 2020 Jan 23 | 2020 Jan 29 | 3,119 | 3,010 | 109 | 4 | NA | NA |
| 6 | 2020 Jan 30 | 2020 Feb 5 | 3,179 | 3,012 | 167 | 6 | NA | NA |
| 7 | 2020 Feb 6 | 2020 Feb 12 | 3,152 | 3,012 | 140 | 5 | NA | NA |
| 8 | 2020 Feb 13 | 2020 Feb 19 | 3,106 | 3,009 | 97 | 3 | NA | NA |
| 9 | 2020 Feb 20 | 2020 Feb 26 | 2,973 | 3,002 | −29 | −1 | NA | NA |
| 10 | 2020 Feb 27 | 2020 Mar 4 | 3,104 | 2,992 | 112 | 4 | 0 | NA |
| 11 | 2020 Mar 5 | 2020 Mar 11 | 3,081 | 2,980 | 101 | 3 | 7 | 14.5 |
| 12 | 2020 Mar 12 | 2020 Mar 18 | 3,286 | 2,964 | 322 | 11 | 99 | 3.3 |
| 13 | 2020 Mar 19 | 2020 Mar 25 | 3,941 | 2,946 | 995 | 34 | 502 | 2.0 |
| 14 | 2020 Mar 26 | 2020 Apr 1 | 4,764 | 2,926 | 1,838 | 63 | 1,003 | 1.8 |
| 15 | 2020 Apr 2 | 2020 Apr 8 | 5,143 | 2,903 | 2,240 | 77 | 1,144 | 2.0 |
| 16 | 2020 Apr 9 | 2020 Apr 15 | 4,565 | 2,879 | 1,686 | 59 | 941 | 1.8 |
| 17 | 2020 Apr 16 | 2020 Apr 22 | 4,109 | 2,853 | 1,256 | 44 | 837 | 1.5 |
| 18 | 2020 Apr 23 | 2020 Apr 29 | 3,692 | 2,827 | 865 | 31 | 558 | 1.5 |
| 19 | 2020 Apr 30 | 2020 May 6 | 3,153 | 2,801 | 352 | 13 | 365 | 1.0 |
| 20 | 2020 May 7 | 2020 May 13 | 2,876 | 2,774 | 102 | 4 | 240 | 0.4 |
| 21 | 2020 May 14 | 2020 May 20 | 2,788 | 2,748 | 40 | 1 | 136 | 0.3 |
| 22 | 2020 May 21 | 2020 May 27 | 2,694 | 2,723 | NA | NA | 112 | −0.3 |
| 23 | 2020 May 28 | 2020 Jun 3 | 2,690 | 2,700 | NA | NA | 61 | −0.2 |
| 24 | 2020 Jun 4 | 2020 Jun 10 | NA | 2,679 | NA | NA | 45 | NA |
| 25 | 2020 Jun 11 | 2020 Jun 17 | NA | 2,660 | NA | NA | 26 | NA |
*COVID-19, coronavirus disease; NA, not applicable. †Week as defined in the death surveillance (running Thursday through Wednesday).
Page created: November 16, 2020
Page updated: January 23, 2021
Page reviewed: January 23, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.